[1]
“Utilization profile of enoxaparin in hospitalized patients with Chronic Kidney Disease in southern Brazil”, Braz. J. Pharm. Sci., vol. 56, p. e18296, Dec. 2020, doi: 10.1590/s2175-97902019000318296.